Literature DB >> 18006940

Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.

Neal L Benowitz1, Sharon M Hall, Susan Stewart, Margaret Wilson, Delia Dempsey, Peyton Jacob.   

Abstract

BACKGROUND: Reducing the nicotine content of cigarettes to make them non-addictive has been widely discussed as a potential strategy for tobacco regulation. A major concern with nicotine reduction is that smokers will compensate for reduced nicotine by smoking more cigarettes and/or smoking more intensively, thereby increasing their exposure to tobacco smoke toxins. This study examined whether gradual reduction in nicotine exposure increases exposure to tobacco smoke toxins.
METHODS: This 10-week longitudinal study of 20 healthy smokers involved smoking their usual brand followed by different types of research cigarettes with progressively lower nicotine content, each smoked for 1 week. Subjects were followed for 4 weeks after returning to smoking their usual brand (or quitting). Smoking behaviors, chemical biomarkers of tobacco smoke exposure, and cardiovascular effect biomarkers were measured.
FINDINGS: Intake of nicotine declined progressively as the nicotine content of cigarettes was reduced, with little evidence of compensation. Cigarette consumption and markers of exposure to carbon monoxide and polycyclic aromatic hydrocarbons, as well as cardiovascular biomarkers remained stable, whereas urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol excretion decreased. Twenty-five percent of participants had spontaneously quit smoking 4 weeks after completing the research cigarette taper. IMPLICATIONS: Our findings with reduced nicotine content cigarettes differ from those of commercial low yields for which compensatory smoking for lower nicotine delivery is substantial. Our data suggest that the degree of nicotine dependence of smokers can be lowered without increasing their exposure to tobacco smoke toxins. Gradual reduction of nicotine content of cigarettes seems to be feasible and should be further evaluated as a national tobacco regulatory strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006940     DOI: 10.1158/1055-9965.EPI-07-0393

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  85 in total

1.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Authors:  Eric C Donny; Rachel L Denlinger; Jennifer W Tidey; Joseph S Koopmeiners; Neal L Benowitz; Ryan G Vandrey; Mustafa al'Absi; Steven G Carmella; Paul M Cinciripini; Sarah S Dermody; David J Drobes; Stephen S Hecht; Joni Jensen; Tonya Lane; Chap T Le; F Joseph McClernon; Ivan D Montoya; Sharon E Murphy; Jason D Robinson; Maxine L Stitzer; Andrew A Strasser; Hilary Tindle; Dorothy K Hatsukami
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

2.  Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes.

Authors:  Lauren R Pacek; Jason A Oliver; Maggie M Sweitzer; F Joseph McClernon
Journal:  Drug Alcohol Depend       Date:  2018-10-26       Impact factor: 4.492

3.  A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Authors:  Andrew C Harris; Paul R Pentel; Danielle Burroughs; Mylissa D Staley; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

Review 4.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

5.  Gradual and immediate nicotine reduction result in similar low-dose nicotine self-administration.

Authors:  Tracy T Smith; Melissa E Levin; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2013-07-01       Impact factor: 4.244

Review 6.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.

Authors:  Saul Shiffman; Brenda F Kurland; Sarah M Scholl; Jason M Mao
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596

8.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

9.  A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings.

Authors:  Melissa Mercincavage; Valentina Souprountchouk; Kathy Z Tang; Rachel L Dumont; E Paul Wileyto; Steven G Carmella; Stephen S Hecht; Andrew A Strasser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-27       Impact factor: 4.254

10.  Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.

Authors:  Tracy T Smith; Joseph S Koopmeiners; Katelyn M Tessier; Esa M Davis; Cynthia A Conklin; Rachel L Denlinger-Apte; Tonya Lane; Sharon E Murphy; Jennifer W Tidey; Dorothy K Hatsukami; Eric C Donny
Journal:  Am J Prev Med       Date:  2019-10       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.